Engineer the needle, skip the haystack
Rather than screening an infinite number of hits to find the needle in the haystack, we combine AI-guided molecular design, precision polymer chemistry and experimental biology to rationally build molecules from the start. We partner Bionic Biologics™ with pharmaceutical, biotechnology and academia to accelerate discovery of first-in-class medicines.
Grove’s Bionic Biologics Platform is an engine for first-in-class drugs for the most challenging disease targets
Your target, any target
We’re target-agnostic. Partner with us to tackle any intracellular or extracellular target of interest.
Potent, cell-active molecules “out of the box” enable rapid go/no-go decisions
In vitro proof-of-concept can be achieved within weeks of project start.
Modular design accelerates lead optimization
Ability to rationally “plug and play” a target-binding peptide domain into the bionic scaffold allows independent optimization of potency and pharmacology.
Highly scalable synthetic process
Our platform chemistry leverages validated, high-yield synthetic processes that enable cost-effective large-scale manufacturing.
